Pacemaker and defibrillator therapy in pediatrics and congenital heart disease

Terrence Chun1

  • 1University of Washington School of Medicine, Children's Heart Center G-0035, Children's Hospital & Regional Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105, USA. terrence.chun@seattlechildrens.org

Future Cardiology
|October 7, 2009
PubMed

Insights

Pacemakers and implantable cardioverter-defibrillators (ICDs) are increasingly used in pediatric patients with congenital heart disease. However, their efficacy and management present unique challenges requiring individualized approaches and novel technical solutions.

Area of Science:

  • Cardiology
  • Pediatric Electrophysiology
  • Medical Device Technology

Background:

  • Pacemaker and defibrillator use is expanding in pediatric populations, including those with congenital heart disease.
  • Rhythm disturbances are prevalent in these patients, yet device therapy efficacy is not fully established.
  • The unique physiology of pediatric patients and congenital heart disease complicates device management.

Purpose of the Study:

  • To review current guidelines and indications for implantable device therapy in children and congenital heart disease patients.
  • To highlight the specific challenges and limitations encountered in device implantation and follow-up for this population.
  • To discuss the need for individualized management and novel approaches in pediatric device therapy.

Main Methods:

  • Review of current literature and clinical guidelines.
  • Analysis of technical challenges in device and lead implantation in pediatric patients.
  • Discussion of individualized management strategies for congenital heart disease patients requiring pacemakers or defibrillators.

Main Results:

  • Current guidelines and indications for pediatric device therapy are presented.
  • Technical difficulties with device and lead implantation necessitate innovative solutions.
  • Device management in this complex population requires a highly individualized approach.

Conclusions:

  • Implantable device therapy in pediatric patients with congenital heart disease presents unique challenges.
  • Novel approaches and individualized management are crucial for successful implantation and follow-up.
  • Further research is needed to establish the efficacy of device therapy in these specific patient groups.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...